Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020

SELL
$14.45 - $24.69 $10.6 Million - $18.1 Million
-734,267 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$19.93 - $29.13 $731,331 - $1.07 Million
-36,695 Reduced 4.76%
734,267 $17.4 Million
Q3 2019

Nov 08, 2019

SELL
$25.47 - $33.37 $279,253 - $365,868
-10,964 Reduced 1.4%
770,962 $21.2 Million
Q2 2019

Jul 25, 2019

SELL
$29.96 - $38.87 $2 Million - $2.6 Million
-66,873 Reduced 7.88%
781,926 $25.9 Million
Q1 2019

May 08, 2019

SELL
$32.77 - $41.99 $87,954 - $112,701
-2,684 Reduced 0.32%
848,799 $29.7 Million
Q4 2018

Feb 05, 2019

BUY
$30.84 - $49.51 $476,632 - $765,177
15,455 Added 1.85%
851,483 $28.3 Million
Q3 2018

Nov 13, 2018

SELL
$42.7 - $56.55 $900,628 - $1.19 Million
-21,092 Reduced 2.46%
836,028 $42.1 Million
Q2 2018

Aug 07, 2018

SELL
$44.1 - $59.85 $9.82 Million - $13.3 Million
-222,668 Reduced 20.62%
857,120 $51.3 Million
Q1 2018

May 08, 2018

SELL
$37.15 - $46.9 $283,343 - $357,706
-7,627 Reduced 0.7%
1,079,788 $49.5 Million
Q4 2017

Feb 12, 2018

SELL
$36.4 - $42.6 $1.45 Million - $1.7 Million
-39,803 Reduced 3.53%
1,087,415 $43.3 Million
Q3 2017

Nov 08, 2017

BUY
$36.75 - $49.65 $41.4 Million - $56 Million
1,127,218
1,127,218 $45.1 Million

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.64B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Rothschild & CO Asset Management Us Inc. Portfolio

Follow Rothschild & CO Asset Management Us Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.